DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/2w2r9l/global_breast) has announced the addition of the "Global Breast Cancer Epidemiology and Patient Flow Analysis - 2012" report to their offering.
Fore Pharma announced the results of its Breast Cancer patient population study in a new report Global Breast Cancer Epidemiology and Patient Flow Analysis - 2012'. The report provides insights into Breast Cancer epidemiology, Breast Cancer diagnosed patients, and Breast Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Breast Cancer derived from epidemiological analysis, percentage of patients diagnosed with Breast Cancer, and percentage of patients treated with Breast Cancer therapy.
The study helps executives estimate Breast Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Breast Cancer prevalence, Breast Cancer diagnosis rate, and Breast Cancer treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Features of the Report:
- Breast Cancer: Disease Definition
- Breast Cancer Patient Flow
- Breast Cancer Prevalence
- Breast Cancer Diagnosed Patients
- Breast Cancer Treated Patients
For more information visit http://www.researchandmarkets.com/research/2w2r9l/global_breast
Source: Research and Markets